Navigating Through 2025: Corporate Governance Structures and Financing Alternatives presented by Cooley
Join Cooley’s life sciences team for an in-depth exploration of the evolving landscape of governance and financing in the life sciences sector. Discover best practices for building robust governance frameworks and staying ahead of related compliance requirements. Gain insights into innovative financing strategies tailored for today’s dynamic market conditions.
Don’t miss this in-person opportunity to sharpen your competitive edge and connect with industry leaders shaping the future of life sciences.
About Cooley life sciences
Cooley is a global law firm and a leader in life sciences and healthcare. As counsel to nearly 50% of the companies on the Nasdaq Biotechnology Index, Cooley also is ranked as the #1 firm for pharma and biotech VC financings by PitchBook. To top it off, Law360 recently honored Cooley life sciences as Practice Group of the Year for 2024. Cooley offers a complete portfolio of scalable, tailored legal solutions that address the complex challenges our life sciences and healthcare clients face in evolving global markets.
Life sciences partnering (LSP)
This workshop features members of Cooley’s life sciences partnering group – a practice of 40+ professionals across the US, UK and Asia, exclusively focused on corporate partnering and licensing transactions specific to life sciences companies. Fifty percent of our LSP lawyers have a master’s or doctorate degree with a life sciences focus, and our team brings decades of experience across a broad range of structures and product stages. Our LSP attorneys are ranked in Chambers, The Legal 500, LMG Life Sciences and Lexology Index. Additionally, Cooley has won the Licensing and Collaboration Firm of the Year award from LMG Life Sciences two times in the last five years.
About our speakers
Alex Abelson – Alex is an associate who represents private companies at all stages of their life cycles, as well as venture capital funds. Alex regularly advises clients on general corporate and private financing matters, with a focus on the life sciences and tech spaces.
Alan Tamarelli – Alan is a partner whose practice focuses on the representation of biotech, pharma, medical device and other life sciences companies in connection with technology-driven strategic transactions. He advises companies on research collaborations and development agreements, intellectual property and technology licensing agreements, and commercial collaborations, including joint ventures, profit-sharing arrangements and co-promotion agreements. He also has experience with manufacturing, distribution, supply and quality agreements, clinical trial agreements, M&A transactions, and life sciences industry-specific matters and counseling.